Home › Bayer to Present Data on Multiple Oncology Compounds at the European...
 

Keywords :   


Bayer to Present Data on Multiple Oncology Compounds at the European...

2013-09-17 16:58:01| Chemicals - Topix.net

These data include an oral presentation of a subanalysis from the Phase III trial of sorafenib in patients with radioactive iodine-refractory differentiated thyroid cancer, an oral presentation and posters on the efficacy and safety of regorafenib, which was recently approved by the European Medicines Agency , and posters on additional analyses ... (more)

Tags: the data present multiple

Category:Chemicals

Latest from this category

All news
25.06Briolf Group to Invest $30 Million in Its First US Production Plant
25.06Sherwin-Williams Announces 2023 Water and Wastewater Impact Award Winners
25.06PPG Partners with ScieneFest Czechia
25.06PPG Partners with ScienceFest Czechia
25.06BASF Decides Against Investment in Nickel-cobalt Refining Complex in Indonesia
25.06Sto Breaks Ground on Manufacturing Facility in Mexico to Support Growth in the Region
25.06CCAI Presents 2024 Student Scholarships
24.06JOHNSTONES PAINT Brand by PPG to be Lead Sponsor of The Masters Snooker Tourney
Chemicals »
26.06VW to invest up to $5bn in Tesla rival Rivian
26.06Strategic use of soybean meal to maximize hog carcass weight during summer
26.06Eastern North Pacific Tropical Weather Outlook
26.06Atlantic Tropical Weather Outlook
26.06Aer Lingus pilots begin industrial action over pay dispute
25.06Water requirements in the summer
25.06New model Is transforming the study of liver abscesses in cattle
25.06Royal Mail buyer to make offer for all staff shares
More »